Sushil Kumar Singh (Sushil K Singh)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 22

Top Venues

Future medicinal chemistry

Journal of biomolecular structure & dynamics

ACS chemical neuroscience

Molecular diversity

Indian Institute of Technology BHU

Indian Institute of Technology BHU (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Indian Institute of Technology BHU

India

Professor :: Department of Pharmaceutical Engineering & Technology

Education History

Indian Institute of Technology BHU

India

PHD :: Department of Pharmaceutical Engineering & Technology

Publications

Srabanti Jana, Tania Nasreen, Sushil Kumar Singh
Discovery of reversible selective monoamine oxidase B inhibitors with anti-acetylcholinesterase activity derived from 4-oxo-N-4-diphenyl butanamides. Future medicinal chemistry 15 (2) (2023)
Srabanti Jana, Tania Nasreen, Sushil Kumar Singh
Discovery of reversible selective monoamine oxidase B inhibitors with anti-acetylcholinesterase activity derived from 4-oxo-N-4-diphenyl butanamides. Future medicinal chemistry 15 (2) (2023)
Srabanti Jana, Tania Nasreen, Sushil Kumar Singh
Discovery of reversible selective monoamine oxidase B inhibitors with anti-acetylcholinesterase activity derived from 4-oxo-N-4-diphenyl butanamides. Future medicinal chemistry 15 (2) (2023)
Kancharla Bhanukiran, Sushil Kumar Singh, Ravi Singh, Ashok Kumar, Siva Hemalatha
Discovery of Multitarget-Directed Ligands from Piperidine Alkaloid Piperine as a Cap Group for the Management of Alzheimer's Disease. ACS chemical neuroscience (2023)
Srabanti Jana, Tania Nasreen, Sushil Kumar Singh
Discovery of reversible selective monoamine oxidase B inhibitors with anti-acetylcholinesterase activity derived from 4-oxo-N-4-diphenyl butanamides. Future medicinal chemistry 15 (2) (2023)
Ankit Ganeshpurkar, Ravi Singh, Pratigya Tripathi, Qadir Alam, Sairam Krishnamurthy, Ashok Kumar, Sushil Kumar Singh
Effect of sulfonamide derivatives of phenylglycine on scopolamine-induced amnesia in rats. Ibrain 9 (1) (2023)
Srabanti Jana, Tania Nasreen, Sushil Kumar Singh
Discovery of reversible selective monoamine oxidase B inhibitors with anti-acetylcholinesterase activity derived from 4-oxo-N-4-diphenyl butanamides. Future medicinal chemistry 15 (2) (2023)
Srabanti Jana, Tania Nasreen, Sushil Kumar Singh
Discovery of reversible selective monoamine oxidase B inhibitors with anti-acetylcholinesterase activity derived from 4-oxo-N-4-diphenyl butanamides. Future medicinal chemistry (2023)
Nilesh Gajanan Bajad, Ashok Kumar, Sushil Kumar Singh
Recent Advances in the Development of Near-Infrared Fluorescent Probes for the in Vivo Brain Imaging of Amyloid-β Species in Alzheimer's Disease. ACS chemical neuroscience (2023)
Asha Anand, Powsali Ghosh, Ravi Singh, Nilesh Gajanan Bajad, Ashok Kumar, Sushil Kumar Singh
Identification of potent histone deacetylase 2 (HDAC2) inhibitors through combined structure and ligand-based designs and molecular modelling approach. Journal of biomolecular structure & dynamics (2023)
Ankit Ganeshpurkar, Ravi Singh, Devendra Kumar, Gopichand Gutti, Pravin Gore, Bharat Sahu, Ashok Kumar, Sushil Kumar Singh
Identification of sulfonamide-based butyrylcholinesterase inhibitors using machine learning. Future medicinal chemistry 14 (14) (2022)
Ravi Singh, Ankit Vyankatrao Pokle, Powsali Ghosh, Ankit Ganeshpurkar, Rayala Swetha, Sushil Kumar Singh, Ashok Kumar
Pharmacophore-based virtual screening, molecular docking and molecular dynamics simulations study for the identification of LIM kinase-1 inhibitors. Journal of biomolecular structure & dynamics (2022)
Powsali Ghosh, Ravi Singh, Ankit Ganeshpurkar, Rayala Swetha, Devendra Kumar, Sushil Kumar Singh, Ashok Kumar
Identification of potential death-associated protein kinase-1 (DAPK1) inhibitors by an integrated ligand-based and structure-based computational drug design approach. Journal of biomolecular structure & dynamics (2022)
Himanshu Rai, Sarika Gupta, Saroj Kumar, Jian Yang, Sushil Kumar Singh, Chongzhao Ran, Gyan Modi
Near-Infrared Fluorescent Probes as Imaging and Theranostic Modalities for Amyloid-Beta and Tau Aggregates in Alzheimer's Disease. Journal of medicinal chemistry 65 (13) (2022)
Rayala Swetha, Anjali Sharma, Ravi Singh, Ankit Ganeshpurkar, Devendra Kumar, Ashok Kumar, Sushil Kumar Singh
Combined ligand-based and structure-based design of PDE 9A inhibitors against Alzheimer's disease. Molecular diversity 26 (5) (2022)
Ankit Ganeshpurkar, Ravi Singh, Devendra Kumar, Gopichand Gutti, Divya Sardana, Shalini Shivhare, Ravi Bhushan Singh, Ashok Kumar, Sushil Kumar Singh
Development of homology model, docking protocol and Machine-Learning based scoring functions for identification of Equus caballus's butyrylcholinesterase inhibitors. Journal of biomolecular structure & dynamics (2021)
Nilesh Gajanan Bajad, Rayala Swetha, Gopichand Gutti, Meenakshi Singh, Ashok Kumar, Sushil Kumar Singh
A systematic review of carbohydrate-based bioactive molecules for Alzheimer's disease. Future medicinal chemistry 13 (19) (2021)
Ravi Singh, Ankit Ganeshpurkar, Powsali Ghosh, Ankit Vyankatrao Pokle, Devendra Kumar, Ravi Bhushan Singh, Sushil Kumar Singh, Ashok Kumar
Classification of beta-site amyloid precursor protein cleaving enzyme 1 inhibitors by using machine learning methods. Chemical biology & drug design 98 (6) (2021)
Supraja Siddamurthi, Gopichand Gutti, Srabanti Jana, Ashok Kumar, Sushil Kumar Singh
Anthraquinone: a promising scaffold for the discovery and development of therapeutic agents in cancer therapy. Future medicinal chemistry 12 (11) (2020)
Srabanti Jana, Sushil Kumar Singh
Identification of human tau-tubulin kinase 1 inhibitors: an integrated e-pharmacophore-based virtual screening and molecular dynamics simulation. Journal of biomolecular structure & dynamics 38 (3) (2019)
Srabanti Jana, Sushil Kumar Singh
Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches. Journal of biomolecular structure & dynamics 37 (4) (2018)
Srabanti Jana, Ankit Ganeshpurkar, Sushil Kumar Singh
Multiple 3D-QSAR modeling, e-pharmacophore, molecular docking, and in vitro study to explore novel AChE inhibitors. RSC advances 8 (69) (2018)

Sushil Kumar Singh.css-eqlu8i{font-size:small;padding-left:4px;} (Sushil K Singh)

Publication Activity (10 Years)

Top Topics

Top Venues

Sushil Kumar Singh (Sushil K Singh)